Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.420
+0.020 (1.43%)
At close: Sep 4, 2026, 4:00 PM EDT
1.415
-0.005 (-0.32%)
After-hours: Sep 4, 2026, 5:05 PM EDT
Acurx Pharmaceuticals Employees
Acurx Pharmaceuticals had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,876,555
Market Cap
7.48M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2024 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Sep 30, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Dec 31, 2021 | 3 | 0 | - | 3 | 0 |
| Mar 31, 2021 | 3 | - | - | 2 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Evogene | 38 |
| Bolt Biotherapeutics | 23 |
| AIM ImmunoTech | 21 |
| Soligenix | 14 |
| Ernexa Therapeutics | 7 |
| Traws Pharma | 7 |
| Alzamend Neuro | 6 |
ACXP News
- 5 days ago - Acurx Pharmaceuticals Proxy statement: Proxy filing - Filings
- 5 days ago - Acurx Pharmaceuticals Proxy statement: Proxy filing - Filings
- 20 days ago - Acurx announces FDA conditional approval of CIFBEZY as brand name for ibezapolst - TheFly
- 20 days ago - Acurx Pharmaceuticals Receives FDA Conditional Acceptance and USPTO Trademark Allowance for the Company's Brand Name for Ibezapolstat - PRNewsWire
- 20 days ago - Acurx receives patents for DNA Polymerase IIIC inhibitors in Mexico and Japan - TheFly
- 23 days ago - Acurx Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 23 days ago - Acurx Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 23 days ago - Acurx Pharmaceuticals Earnings release: Q2 2026 - Filings